Clinical Trials Directory

Trials / Completed

CompletedNCT02193009

SipSmarter: A Nutrition Literacy Approach to Reducing Sugary Beverages

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
304 (actual)
Sponsor
Virginia Polytechnic Institute and State University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The primary aim of this pragmatic randomized-controlled trial was to determine the effectiveness of a scalable 6-month intervention aimed at decreasing SSB consumption (SIPsmartER) when compared to a matched contact physical activity promotion control group (MoveMore).

Detailed description

The primary aim of this application targeting at-risk residents from rural southwest Virginia counties is to: 1\. Determine the effectiveness of SIPsmart and SIPsmartER at decreasing SSB consumption when compared to a matched contact control group targeting walking behaviors. The secondary aims are to: 1. Explore causal pathways through which changes in SSB attitudes, subjective norms, and perceived behavioral control influence behavioral intentions and SSB consumption, and the extent to which changes in SSB consumption are mediated by changes in nutrition numeracy and nutrition-related media literacy. 2. Determine the reach and representativeness, adoption feasibility, degree to which the intervention was implemented as intended (and associated costs), and the maintenance of behavior changes 6 and 12 months post intervention (i.e., 18 months from baseline) when compared to control. 3. Assess intervention impacts on body weight. An exploratory aim is to: 1\. Assess intervention impacts on a 13C biomarker, a new non-invasive biomarker fingerstick technique for added sugar intake, and evaluate the changes in this biomarker over time.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSipSmarter6-month behavioral trial
BEHAVIORALMoveMore6 month behavioral trial

Timeline

Start date
2011-07-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2014-07-17
Last updated
2022-04-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02193009. Inclusion in this directory is not an endorsement.